Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
---|---|---|---|---|---|
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 2650 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 3298 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 4172 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 42690 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 49382 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 54794 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 62279 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 67060 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 68174 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 70218 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 75440 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 81085 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 83847 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 90793 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 97802 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 99080 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 99937 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 101943 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 102134 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 103479 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 107445 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 107779 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 109668 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 110402 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 112549 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 113893 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 115660 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 116812 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 118148 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 118599 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 118648 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 119820 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 119930 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 120306 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 121141 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 124449 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 125271 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 127367 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 127380 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 127783 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 128672 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 129390 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 130282 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 131009 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 131103 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 131352 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 132021 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 132072 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 132304 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 132328 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 132857 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 134023 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 135135 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 135245 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 136125 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 137124 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 138176 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 139043 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 139280 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 141098 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 141129 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 141428 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 141620 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 144008 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 144675 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 145158 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 145607 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 145790 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 147589 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 147711 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 148115 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 148226 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 149702 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 150814 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 152211 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 152335 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 152344 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 152496 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 152554 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 153115 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 153158 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 153933 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 154145 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 154757 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 155166 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 155517 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 155602 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 156051 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 156944 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 157191 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 158411 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 158829 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 159009 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 160073 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 160944 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 161417 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 163039 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 163200 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 163290 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 164898 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 165252 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 165487 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 166085 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 166358 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 166949 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 166978 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 166985 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 167614 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 167672 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 167681 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168036 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168077 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168250 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168327 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168328 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168423 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168538 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168564 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168577 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168606 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168713 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 168832 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169276 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169300 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169409 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169416 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169466 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169582 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169606 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169616 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169721 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169723 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 169916 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170040 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170072 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170114 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170140 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170228 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170408 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170418 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170569 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170901 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 170979 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171021 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171166 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171753 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171792 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171831 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 171881 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 172156 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 172406 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 172426 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 173331 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 173672 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 174350 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 174617 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 174968 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 175334 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 176135 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 176451 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 177025 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 177892 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 178001 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 178100 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 178821 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 179197 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 179492 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 179827 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 180028 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 180369 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 181189 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 181310 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 181829 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 182190 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 182522 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 183309 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 183611 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 184701 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 184753 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 184783 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 184788 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 184983 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 185726 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 186036 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 186215 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 186289 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 186302 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 187012 | Peak area normalized | red cross plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 187466 | Peak area normalized | chear plasma | - |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 187565 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 187614 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 190371 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 191397 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 191869 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 191996 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 193198 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 193430 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 194047 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 195164 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | cortisone@7.57 | 195295 | Peak area normalized | Sample | male |
Return to search page